Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

NORCROSS, Ga., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results for the three months ended June 30, 2017. These results are included in the Company’s Quarterly Report on Form 10-Q, which has been filed with the U.S. Securities and Exchange … [Read more...]

Norfolk, Virginia, Enlists Arcadis to Design Stormwater Flood Protections

NORFOLK, Va., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Arcadis (EURONEXT:ARCAD), the leading global design and consultancy firm for natural and built assets, has been awarded an approximate $11.6 million contract by the City of Norfolk, Virginia, to design stormwater infrastructure enhancements to protect Ohio Creek communities against future flooding and continued sea level rise. … [Read more...]

Slowing ships a good start for North Atlantic right whales

TORONTO, Aug. 11, 2017 (GLOBE NEWSWIRE) -- The following statement from WWF-Canada president and CEO David Miller is in response to this Government of Canada announcement of new measures to protect North Atlantic right whales.  “WWF-Canada is pleased that the Government of Canada has taken measures to slow ships in areas where endangered North Atlantic right whales are … [Read more...]

$7.48 Million in Grants for Great Lakes Restoration Announced by Sustain Our Great Lakes Partnership

WASHINGTON, D.C., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Sustain Our Great Lakes partners this week announced $7.48 million in grant funding for 23 ecological restoration projects in the Great Lakes basin. Approximately $12.06 million in additional project support will be leveraged by grantees, for a total on-the-ground conservation impact of $19.54 million. The grants will … [Read more...]

CytomX to Present at the 2017 Wedbush PacGrow Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the 2017 Wedbush PacGrow Healthcare Conference.  Debanjan Ray, chief financial officer and head of corporate development will deliver a corporate … [Read more...]